Publication

Comparative Pharmacokinetics of Two Extended-Release Tablet Formulations of Upadacitinib: Bioequivalence Assessment

Explore how ER upadacitinib formulations met 80–125% bioequivalence criteria under fasting and fed conditions using…

CertaraJune 1, 2026

Publication

Effect of High-Fat Meal on the Pharmacokinetics and Safety of Lansoprazole Enteric-Coated Capsules in Healthy Chinese Subjects

Discover how high-fat meal reduces lansoprazole exposure by up to 61% in a bioequivalence study…

CertaraJune 1, 2026

Fact Sheet

Certara’s NLME Engine: Setting the Standard for Run Speed and Stability

Why pharmacometricians are turning to the NLME engine from Certara Phoenix

CertaraMay 28, 2026

On-Demand Webinar

Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned

Learn how Phoenix NLME and RsNLME support advanced PK/PD workflows and complex pharmacometric modeling through…

CertaraMay 20, 2026

Publication

The pharmacokinetics/pharmacodynamics index of high-dose tigecycline in patients with carbapenem-resistant Enterobacterales bloodstream infection: a prospective study

Learn how prospective study identifies AUC/MIC ≥ 9.90 as a PK/PD target for high-dose tigecycline…

CertaraMay 20, 2026

On-Demand Webinar

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve.

Danielle PillsburyMay 8, 2026

Blog

What we learned at Phoenix UGM at Certainty 2026 about the future of PK/PD

JTVCdGVhbV9qdW1wX2xpc3QlNUQ= May 8, 2026 At Certainty 2026, the Phoenix User Group Meeting brought together scientists,…

CertaraMay 8, 2026

On-Demand Webinar

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

Explore how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity,…

CertaraMay 6, 2026

Blog

GxP compliance in the cloud: What IT teams need to rethink

Learn how GxP validation works in modern SaaS and cloud environments, with best practices for…

CertaraMay 4, 2026

Webinar

ICH M13B Strength Biowaiver

CertaraApril 28, 2026

Certara Products – Phoenix

Comparative Pharmacokinetics of Two Extended-Release Tablet Formulations of Upadacitinib: Bioequivalence Assessment

Effect of High-Fat Meal on the Pharmacokinetics and Safety of Lansoprazole Enteric-Coated Capsules in Healthy Chinese Subjects

Certara’s NLME Engine: Setting the Standard for Run Speed and Stability

Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned

The pharmacokinetics/pharmacodynamics index of high-dose tigecycline in patients with carbapenem-resistant Enterobacterales bloodstream infection: a prospective study

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

What we learned at Phoenix UGM at Certainty 2026 about the future of PK/PD

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

GxP compliance in the cloud: What IT teams need to rethink

ICH M13B Strength Biowaiver

Newsletter sign up

Quick links

Solutions

Contact